


Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial Approach

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
